Markedly Reduced Azithromycin and Ceftriaxone Susceptibility in Commensal Neisseria Species in Clinical Samples From Belgian Men Who Have Sex With Men

Clin Infect Dis. 2021 Jan 27;72(2):363-364. doi: 10.1093/cid/ciaa565.

Authors

Jolein G E Laumen¹, Christophe Van Dijck¹, Said Abdellati¹, Sheeba S Manoharan-Basil¹, Irith De Baetselier¹, Delphine Martiny^{2

3}, Tania Crucitti⁴, Chris Kenyon¹

Affiliations

¹ Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
² Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles, Pôle Hospitalier Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
³ Faculté de Médecine et Pharmacie, Université de Mons, Mons, Belgium.
⁴ Centre Pasteur du Cameroun, Yaounde, Cameroon.

PMID: 33501961
DOI: 10.1093/cid/ciaa565

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Azithromycin / pharmacology
Belgium / epidemiology
Ceftriaxone / pharmacology
Cephalosporins
Gonorrhea* / drug therapy
Gonorrhea* / epidemiology
Homosexuality, Male
Humans
Male
Neisseria
Neisseria gonorrhoeae
Sexual and Gender Minorities*
Vietnam

Substances

Anti-Bacterial Agents
Cephalosporins
Ceftriaxone
Azithromycin